Medicine and Dentistry
Cohort Analysis
100%
Inflammatory Bowel Disease
60%
Crohn's Disease
40%
Ulcerative Colitis
38%
Childbirth
31%
Birth Outcomes
31%
Odds Ratio
25%
Conception
21%
Drug Therapy
20%
Disease Activity
18%
Patient with Inflammatory Bowel Disease
17%
Assisted Reproductive Technology
17%
Congenital Disorder
17%
Premature Labor
16%
Patient with Crohn's Disease
14%
Assisted Reproduction
14%
Disease
13%
Mercaptopurine
12%
Infection
12%
Azathioprine
10%
Patient with Ulcerative Colitis
10%
Symptom
10%
Tumor Necrosis Factor
10%
Chronic Disease
9%
Health Outcomes
9%
Child
9%
Small for Gestational Age
9%
Embryo Transfer
9%
Opiate
8%
TNF Inhibitor
8%
Hazard Ratio
8%
Postoperative Complication
7%
Case-Control Study
7%
Multiple Sclerosis
7%
Urine Incontinence
6%
Neuro-Oncology
6%
Congenital Malformation
6%
Cesarean Section
6%
Thyroid Disease
6%
Rheumatoid Arthritis
5%
Prevalence
5%
Quality of Life
5%
Pediatrics
5%
Malignant Neoplasm
5%
Paternal Exposure
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
90%
Inflammatory Bowel Disease
53%
Crohn's Disease
47%
Ulcerative Colitis
40%
Disease Activity
21%
Mercaptopurine
19%
Disease
16%
Infection
16%
Congenital Disorder
16%
Premature Labor
15%
Tumor Necrosis Factor Inhibitor
13%
Multiple Sclerosis
12%
Azathioprine
9%
Tumor Necrosis Factor
9%
Chronic Disease
9%
Small for Date Infant
9%
Rheumatoid Arthritis
8%
Congenital Malformation
8%
Infliximab
7%
Aminosalicylic Acid
7%
Selective Serotonin Reuptake Inhibitor
6%
Case-Control Study
6%
Thyroid Disease
6%
Methotrexate
6%
Corticosteroid
6%
Inflammatory Disease
5%
